Page last updated: 2024-09-04

ampelopsin and Melanoma

ampelopsin has been researched along with Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YM; Peng, Y; Sun, HY; Yue, JQ; Zhong, ZJ; Zhou, DZ1
Chen, H; Li, M; Liu, B; Liu, J; Zeng, G; Zhang, Q; Zhu, R1

Other Studies

2 other study(ies) available for ampelopsin and Melanoma

ArticleYear
Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells.
    Free radical research, 2017, Volume: 51, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cytoprotection; Drug Screening Assays, Antitumor; Flavonols; Humans; Melanoma; NF-kappa B; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms

2017
Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells.
    Oncology reports, 2014, Volume: 31, Issue:6

    Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavonols; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Neoplasm Proteins

2014